-
Product Insights
Kingline Ondo IPP Power Plant Phase II
Kingline Ondo IPP Power Plant Phase II is a thermal project located in Ondo, Nigeria. The project is owned by Denham Capital Management LP; Kingline Ondo IPP Ltd; Themis Energy and is developed by Kingline Ondo IPP Ltd; Themis Energy. The project is at the permitting stage. Empower your strategies with our Kingline Ondo IPP Power Plant Phase II report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report...
-
Product Insights
Tetetou
Tetetou is a Hydro project located in Plateaux, Togo. The project is owned by Ministry of Mines and Energy, Togo and is developed by Themis SA. The project is at the permitting stage. Empower your strategies with our Tetetou report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the...
-
Product Insights
Kingline Ondo IPP Power Plant Phase I
Kingline Ondo IPP Power Plant Phase I is a thermal project located in Ondo, Nigeria. The project is owned by Kingline Ondo IPP Ltd and is developed by Kingline Ondo IPP Ltd; Themis Energy. The project is at the permitting stage. Empower your strategies with our Kingline Ondo IPP Power Plant Phase I report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to...
-
Product Insights
Sahofika
Sahofika is a 192MW hydro power project located in Antananarivo, Madagascar. It is being developed by Nouvelle Energie Hydroelectrique de l'Onive. The project is currently in the permitting stage. The project is owned by Eiffage SA; Eranove SA; Themis SA. Sahofika profile includes core details such as plant name, technology, capacity, status, plant proponents (owners, developers etc.), owner stakes etc as well as key operational data including generation, year online, decommissioning year, capital expenditure etc. Details on project specific contacts...
-
Track & Monitor
Innovation in Healthcare: Thermal Ablation Instruments
Innovations in healthcare industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in healthcare industry. Using patent data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they are emerging, accelerating or...
-
Sector Analysis
Contract Injectable Packaging Trends in the Bio/Pharma Industry
Injectables and their packaging requirements are very important to marketed treatments given the volume of vaccines required to tackle the COVID-19 pandemic and the rising number of biologics in development pipelines and on the market. Most injectable drugs in the development pipeline are biologics, which will become increasingly approved and more established in the treatment landscape in the future. The top contract packaging organizations (CPOs) for injectables by the number of contracts are standalone packagers along with large CMOs which...
-
Product Insights
Lassa Fever (Lassa Hemorrhagic Fever) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Lassa Fever (Lassa Hemorrhagic Fever) pipeline market research report provides comprehensive information on the therapeutics under development for Lassa Fever (Lassa Hemorrhagic Fever), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for...
-
Sector Analysis
Outlook for Viral Vector Contract Manufacturing – Gene Therapies, Cell Therapies, and COVID-19 Vaccines
The bio/pharmaceutical industry is experiencing a shortage of viral vectors, a component needed to produce gene therapies and gene-modified cell therapies, as well as certain COVID-19 vaccines that require a viral vector, notably those from AstraZeneca and Johnson & Johnson (J&J). This report reveals that viral vector production is limited by insufficient manufacturing capacity, an inefficient manufacturing process, and the requirement for complex specialist facilities. There are 14 therapies/vaccines that use a viral vector (gene therapies, gene-modified cell therapies, and...
-
Sector Analysis
Coronavirus Disease 2019 (COVID-19) Vaccines – Contract Development and Manufacturing Landscape
This expert trend report is a comprehensive look at the contract manufacturing landscape surrounding COVID-19 Vaccine in 2020, including analysis of pipeline drugs, clinical trials, CMO activity, Contract Manufacturing Service Agreements, and funding for manufacturing of COVID-19 Vaccines. It is a critical source for strategic planning efforts and will improve understanding of crucial components of the supply chain that will provide insights for supplier selection and management.
-
Product Insights
Muscle Spasm Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Muscle Spasm Global Clinical Trials Review, H1, 2018" provides an overview of Muscle Spasm clinical trials scenario. This report provides top line data relating to the clinical trials on Muscle Spasm. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...